CA1142828A - Nasal protective method and device - Google Patents
Nasal protective method and deviceInfo
- Publication number
- CA1142828A CA1142828A CA000376781A CA376781A CA1142828A CA 1142828 A CA1142828 A CA 1142828A CA 000376781 A CA000376781 A CA 000376781A CA 376781 A CA376781 A CA 376781A CA 1142828 A CA1142828 A CA 1142828A
- Authority
- CA
- Canada
- Prior art keywords
- nubs
- nose
- splint
- nasal
- spring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Abstract
ABSTRACT
Protective method and apparatus for the nasal passages comprising a U-shaped wire spring each leg of which being embedded within, and held by friction, an ellipsoidal-like nub for closing the nose by pressing in on its sides and to raise the temperature of the nasal passages.
Protective method and apparatus for the nasal passages comprising a U-shaped wire spring each leg of which being embedded within, and held by friction, an ellipsoidal-like nub for closing the nose by pressing in on its sides and to raise the temperature of the nasal passages.
Description
NA5AL PROTECTIVE ~ETHOD AND DEVICE
Cross-Re~erence to Related Application This application is an improvement over that of Applicant's U.S. Patent No. ~,033,342 issued on July 5, 1977 and entitled "Nasal Protective Splint".
Back~r_nd of the Invention Fie~ld of the Invention This invention relates to an improvement in nasal protectors for the protection of the mucous membranes of the nasal passages.
Descri~t on of the Prior Art The Prior art teaches that use of numerous nasal protective devices, but does not teach the use of a device that closes off the nasal passages for the purpose of creat-ing in the nose nasal passage a condition substantiallyequivalent to inflammation, the natural defensive reaction to irritation.
U.S. Patent No. 2,317,236 is typical of the prior art wherein a nose clip closes the nasal passages but under conditions that will not develop the na-tural defensive reaction of inflammation.
Summar~ of the Invention The apparatus of the invention is a nasal splint having a U-shaped wire spring with an ellipsoidal-like shaped nub on each leg of the spring. Each nub is rotationally and longitudinally adjustable with regard to each leg of the spring to adjust the splint to human noses of different sizes.
`~
The method of using the inventive device above requires that the splint be positioned on the nose to close off the nasal passages and exert a firm pressure on the septum for a period of 30 minutes or more causing the nasal temperature to rise sufficiently to create a condition in the nose substantially equivalent to inflammation, the natural defensive reaction to ~rr~tation but without the ~in and suffering of inflamed and swollen membranes.
Brief Description of the Drawing Figure 1 illustrates the nasal splint in use.
Figure 2 is a perspective view of the nasal splint, and Figure 3 is a cross-sectional view of the ends of the nasal splint.
Description of the Preferred Embodiments This invention relates to an improvement in nasal protectors and has for its object the protection of the mucous membranes of the nasal passages. To this end inhalation of airborne irritants entering the nose are trapped and minimized;
reactions to a stimulus (which are manifested by snee~ing) are inhibited, and "inflammation" (the natural defensive reaction to irritation~ is simulated.
Toward this objective (1) the nose of the human is closed to a degree sufficient to trap and minimize inhalation of airborne irritants entering the nose but insufficient to block breathing and watery secretions therefrom, ~2~ the nose is wholly closed off by exerting a firm pressure on its sides for 30 minutes or more (during which time forceful attempts to inhale through nose should be exarcised) to $~
inhibit the explosive actions of sneezing by control of voluntary muscles of the nose, and (3) the nasal temperature is caused to rise sufficient to create a condition substant-ially equivalent to inflammation (inflamed and swollen membranes), the natural defensive mechanism of the nose.
Thus precluding or abating the inflammatory process whereby the evils therefrom are arrested or alleviated.
The means employed for implementing this invention is a small improved nasal splint comprising a resilient and adjustable music wire spring 2 (ranging in diameter 0.030 of an inch) each leg 4 and 6 of which is embedded along the central axis holding by fric-tion an ellipsoidal-like nub 8 and 10, preferably of polyethylene, having a certain elastic quality to permit adjustment of each nub along and around each leg of the spring, thus adapting the nasal splint to conform with comfort to the size ancl shape of the nose.
This invention has two unique improvements over that of my previous Patent No. 4,033,342, issued July 5, 1977.
In that patent, each le~ of the U-shaped spring was rigidly embedded in a different one of the nubs, whereas in this improved invention, each nub is held to a dif~erent leg of the spring only by friction but with sufficient gripping power thus providing for easy adjustment, more comfort to the wearer and adaptability to conform with the shape and size of nose.
The second and major improvement in this invention is the period of time of closing off the nasal passages.
In my previous Patent No. 4,033,342, the time period of closing the nose was only two or three minutes for the purpose of inhibiting sneezing. Whereas this improved invention requires closing off the nose for a period of 30 minutes or more causing a rise in nasal temperature and thus creating a temporary condition in the nose substantially equivalent to inflammation, the natural defensive mechanism of the nose.
During the fall, winter and spring seasons particularly, the nasal mucous membranes of the individual are subjected to attack by countless airborne irritants which are constantly being breathed into the nose, some of which are often in-fectious. Many of these agents, after entering the nose, are conveyed by the mucous blanket back to the throat where they are s~allowed and rendered harmless. But, unfortunately, some succeed in escaping this movement to the throat and, instead, land in and attack the membranes. Irritation then begins and evils generate and develop. When this condition is reached, the individual soon succumbs to the explosive ~OhS of sneezing -- and as sneezing is well known to irritate the nasal mucous membranes -- the problem then becomes compounded, causing a rapid development of the in-flammatory process which results in nasal blockage and in other complications. When an irritating agent attacks the nasal mucosa, irritation therefrom ensues. Two things then promptly occur, (1) the small vessels of the nasal membranes dilate and watery secretions therefrom are increased, and
Cross-Re~erence to Related Application This application is an improvement over that of Applicant's U.S. Patent No. ~,033,342 issued on July 5, 1977 and entitled "Nasal Protective Splint".
Back~r_nd of the Invention Fie~ld of the Invention This invention relates to an improvement in nasal protectors for the protection of the mucous membranes of the nasal passages.
Descri~t on of the Prior Art The Prior art teaches that use of numerous nasal protective devices, but does not teach the use of a device that closes off the nasal passages for the purpose of creat-ing in the nose nasal passage a condition substantiallyequivalent to inflammation, the natural defensive reaction to irritation.
U.S. Patent No. 2,317,236 is typical of the prior art wherein a nose clip closes the nasal passages but under conditions that will not develop the na-tural defensive reaction of inflammation.
Summar~ of the Invention The apparatus of the invention is a nasal splint having a U-shaped wire spring with an ellipsoidal-like shaped nub on each leg of the spring. Each nub is rotationally and longitudinally adjustable with regard to each leg of the spring to adjust the splint to human noses of different sizes.
`~
The method of using the inventive device above requires that the splint be positioned on the nose to close off the nasal passages and exert a firm pressure on the septum for a period of 30 minutes or more causing the nasal temperature to rise sufficiently to create a condition in the nose substantially equivalent to inflammation, the natural defensive reaction to ~rr~tation but without the ~in and suffering of inflamed and swollen membranes.
Brief Description of the Drawing Figure 1 illustrates the nasal splint in use.
Figure 2 is a perspective view of the nasal splint, and Figure 3 is a cross-sectional view of the ends of the nasal splint.
Description of the Preferred Embodiments This invention relates to an improvement in nasal protectors and has for its object the protection of the mucous membranes of the nasal passages. To this end inhalation of airborne irritants entering the nose are trapped and minimized;
reactions to a stimulus (which are manifested by snee~ing) are inhibited, and "inflammation" (the natural defensive reaction to irritation~ is simulated.
Toward this objective (1) the nose of the human is closed to a degree sufficient to trap and minimize inhalation of airborne irritants entering the nose but insufficient to block breathing and watery secretions therefrom, ~2~ the nose is wholly closed off by exerting a firm pressure on its sides for 30 minutes or more (during which time forceful attempts to inhale through nose should be exarcised) to $~
inhibit the explosive actions of sneezing by control of voluntary muscles of the nose, and (3) the nasal temperature is caused to rise sufficient to create a condition substant-ially equivalent to inflammation (inflamed and swollen membranes), the natural defensive mechanism of the nose.
Thus precluding or abating the inflammatory process whereby the evils therefrom are arrested or alleviated.
The means employed for implementing this invention is a small improved nasal splint comprising a resilient and adjustable music wire spring 2 (ranging in diameter 0.030 of an inch) each leg 4 and 6 of which is embedded along the central axis holding by fric-tion an ellipsoidal-like nub 8 and 10, preferably of polyethylene, having a certain elastic quality to permit adjustment of each nub along and around each leg of the spring, thus adapting the nasal splint to conform with comfort to the size ancl shape of the nose.
This invention has two unique improvements over that of my previous Patent No. 4,033,342, issued July 5, 1977.
In that patent, each le~ of the U-shaped spring was rigidly embedded in a different one of the nubs, whereas in this improved invention, each nub is held to a dif~erent leg of the spring only by friction but with sufficient gripping power thus providing for easy adjustment, more comfort to the wearer and adaptability to conform with the shape and size of nose.
The second and major improvement in this invention is the period of time of closing off the nasal passages.
In my previous Patent No. 4,033,342, the time period of closing the nose was only two or three minutes for the purpose of inhibiting sneezing. Whereas this improved invention requires closing off the nose for a period of 30 minutes or more causing a rise in nasal temperature and thus creating a temporary condition in the nose substantially equivalent to inflammation, the natural defensive mechanism of the nose.
During the fall, winter and spring seasons particularly, the nasal mucous membranes of the individual are subjected to attack by countless airborne irritants which are constantly being breathed into the nose, some of which are often in-fectious. Many of these agents, after entering the nose, are conveyed by the mucous blanket back to the throat where they are s~allowed and rendered harmless. But, unfortunately, some succeed in escaping this movement to the throat and, instead, land in and attack the membranes. Irritation then begins and evils generate and develop. When this condition is reached, the individual soon succumbs to the explosive ~OhS of sneezing -- and as sneezing is well known to irritate the nasal mucous membranes -- the problem then becomes compounded, causing a rapid development of the in-flammatory process which results in nasal blockage and in other complications. When an irritating agent attacks the nasal mucosa, irritation therefrom ensues. Two things then promptly occur, (1) the small vessels of the nasal membranes dilate and watery secretions therefrom are increased, and
(2) nature reacts to this irritation by sneezing which appears to be nature's way of removing the agent that is causing ~5--the irritation. If the causative agent is non-infectious, sneezing will often dislodge i-t and the secretions, which are part of nature's defense cycle, can wash it back in the throat to be swallowed. However, the non-infectious invader can often become so entrenched in the nasal mucosa that sneezin~ will fail to dislodge it, and along with its continued irritation coupled with that from sneezing, complications can surely be expected to follow. If, on the other hand, the irritation is being caused by an infectious agent, a different situation develops~ that is, the agent has succeeded in gaining entrance to a living cell from which it gains protection :Erom being dislodged by sneezing. So here again, an invader is inflicting irr.itation and setting the stage for complications to follow, which in this case are perhaps more serious. In both of these cases, irritation of the nasal passages causes the inflammatory process to develop, resulting in nasal blockage and inflamed membranes, but when the inflam-matory process is caused by an infectious agent, favorable conditions are thereby created under which this infectious agent may multiply and produce results that are injurious.
An object of this invention first of all is to (1) reduce to a minimum the inhalation of irritating agents entering the nose, (2) inhibit the reactions of sneezing to these irritants which escape the mucous blanket and initiate irritation in the nasal mucosa, and (3) simulate i.nflammation, the natural defensive reaction to irritation.
From my own observations and clinical studies by re-search scientists, .he average nasal disorder generally called a common he~ad cold or hay Eever is diagnosed usually only by guess. But one thing is ~uite certain, the symptoms are virtually the same. The disorder is generally sensed by repeated spells of sneezing, water dropping from nose and, at times, a slight scratchy feeling in the throat. During the first 36 to 48 hours, all the usual painful symptoms are developing until the peak of nasal obstruction is finally reached and then something significant happens. That is, all symptoms are brought to a halt and begin shortly there-after to subside progressively toward zero, but it takesfive or more days for all symptoms to disappear.
What brought about this pehnomenon? It cannot be credited to antibodies because more than one clinical study has discovered that the antibodies present in such cases are not due to the infecting virus. So the overcoming of such illnesses is left in the hands of mother nature to develop inflammation (heat and swelling) as the last resort to end such disorders. And those two vital conditions, heat (increased nasal temperature~ and swelling (nasal blocka~e~, provide the defensive action which ultimately overcomes nasal disorders such as hay fever and common head colds. Thus, when the nose is closed with this nasal splint, nasal blockage occurs and the nasal temperature rises, thereby simulating or mimicking inflammation, the natural defensive mechanism, of the nose.
In brief, this improved method of prolonging the time of closing off the nasal passages is precisely the differ-ence between failure and success in preventing the inflammatory process and arresting nasal disorders. Hence, when repeated spells of sneezing occur, the nasal splint should be adjusted and applied to close off the nasal passages and to exert a firm pressure on the nasal septum (position l, Fig. l); and while holding this position for a period of 30 minutes or more, forceful attempts to inhale through the nose should be exercised. At the end of the said period, adjust the splint to a degree only sufficient to braathe comfortably through the nose, yet retain a degree of con-striction in the nasal passages (position 1', Fig. 1).In this adjusted position of the nasal splint, it will trap and minimize inhalation of irritants entering the nose and enhance its filtering system. It can be worn in this position as long as desired with safety and little or no discomfort.
It should be noted that when the nasal mucous membranes are under attack, watery secretions of the nose occur.
By actual experience, I have discovered that blotting these secretions rather than blowing the nose has proved most helpful toward achieving the objective of the invention.
Furthermore, use of this nasal splint will operate as a deterrent to nose blowing.
This invention resides not merely in using a nasal clip, but in making a nasal protective splint adaptable for a new and inventive use. The prime object of the invention is to fulfill a health need long desired but never attained which fact is manifested by its absence of availability for public benefit. ~y invention is novel since it is out of the ordinary and unobvious because it is insufficientl~
e~ident as to arres-t attention.
The nasal splint has striking properties over conventional nasal protective devices, namely, (1) practicabilit~ (more acceptable for public use); (2) less unsightl~ to wear;
t3) comfortable to wear; (4) no health hazard; (5) manu-facturing costs will be at a minimum since it comprises only two simple parts; (6~ a lower price level can be created by making volume production easier.
10 In two tests to determine rise in temperature in the nasal passages, the ~ollowing temperature/times were recorded:
Test 1 Time Nose Closed Off Temperature = (mins.) in Nasal Passage 15 0 33.5C. (92.3F.) 35.8C. (96.4F.) 36.4C. (97.5F.) 36.5C. (97.7F.) 36.5C. (97.7F.) 36.7C. (98.06F.) 36.7C. (98.06F.) Test II
20Time Nose Closed Off Temperature (mins.) in Nasal Passage _ 0 33C. (91.4F.) 35.8C. (96.4F.) 36.4C, (97.5F~) 36.6C. (97.8F.) 36.6C. (97.8F.) During both tests, the temperature in the mouth was 97.~F.
The average normal temperature in the nose is 33C. (91.4F.).
The higher temperatures are in the range of inflamed nasal mucous membranes, a vital condition of inflammation.
An object of this invention first of all is to (1) reduce to a minimum the inhalation of irritating agents entering the nose, (2) inhibit the reactions of sneezing to these irritants which escape the mucous blanket and initiate irritation in the nasal mucosa, and (3) simulate i.nflammation, the natural defensive reaction to irritation.
From my own observations and clinical studies by re-search scientists, .he average nasal disorder generally called a common he~ad cold or hay Eever is diagnosed usually only by guess. But one thing is ~uite certain, the symptoms are virtually the same. The disorder is generally sensed by repeated spells of sneezing, water dropping from nose and, at times, a slight scratchy feeling in the throat. During the first 36 to 48 hours, all the usual painful symptoms are developing until the peak of nasal obstruction is finally reached and then something significant happens. That is, all symptoms are brought to a halt and begin shortly there-after to subside progressively toward zero, but it takesfive or more days for all symptoms to disappear.
What brought about this pehnomenon? It cannot be credited to antibodies because more than one clinical study has discovered that the antibodies present in such cases are not due to the infecting virus. So the overcoming of such illnesses is left in the hands of mother nature to develop inflammation (heat and swelling) as the last resort to end such disorders. And those two vital conditions, heat (increased nasal temperature~ and swelling (nasal blocka~e~, provide the defensive action which ultimately overcomes nasal disorders such as hay fever and common head colds. Thus, when the nose is closed with this nasal splint, nasal blockage occurs and the nasal temperature rises, thereby simulating or mimicking inflammation, the natural defensive mechanism, of the nose.
In brief, this improved method of prolonging the time of closing off the nasal passages is precisely the differ-ence between failure and success in preventing the inflammatory process and arresting nasal disorders. Hence, when repeated spells of sneezing occur, the nasal splint should be adjusted and applied to close off the nasal passages and to exert a firm pressure on the nasal septum (position l, Fig. l); and while holding this position for a period of 30 minutes or more, forceful attempts to inhale through the nose should be exercised. At the end of the said period, adjust the splint to a degree only sufficient to braathe comfortably through the nose, yet retain a degree of con-striction in the nasal passages (position 1', Fig. 1).In this adjusted position of the nasal splint, it will trap and minimize inhalation of irritants entering the nose and enhance its filtering system. It can be worn in this position as long as desired with safety and little or no discomfort.
It should be noted that when the nasal mucous membranes are under attack, watery secretions of the nose occur.
By actual experience, I have discovered that blotting these secretions rather than blowing the nose has proved most helpful toward achieving the objective of the invention.
Furthermore, use of this nasal splint will operate as a deterrent to nose blowing.
This invention resides not merely in using a nasal clip, but in making a nasal protective splint adaptable for a new and inventive use. The prime object of the invention is to fulfill a health need long desired but never attained which fact is manifested by its absence of availability for public benefit. ~y invention is novel since it is out of the ordinary and unobvious because it is insufficientl~
e~ident as to arres-t attention.
The nasal splint has striking properties over conventional nasal protective devices, namely, (1) practicabilit~ (more acceptable for public use); (2) less unsightl~ to wear;
t3) comfortable to wear; (4) no health hazard; (5) manu-facturing costs will be at a minimum since it comprises only two simple parts; (6~ a lower price level can be created by making volume production easier.
10 In two tests to determine rise in temperature in the nasal passages, the ~ollowing temperature/times were recorded:
Test 1 Time Nose Closed Off Temperature = (mins.) in Nasal Passage 15 0 33.5C. (92.3F.) 35.8C. (96.4F.) 36.4C. (97.5F.) 36.5C. (97.7F.) 36.5C. (97.7F.) 36.7C. (98.06F.) 36.7C. (98.06F.) Test II
20Time Nose Closed Off Temperature (mins.) in Nasal Passage _ 0 33C. (91.4F.) 35.8C. (96.4F.) 36.4C, (97.5F~) 36.6C. (97.8F.) 36.6C. (97.8F.) During both tests, the temperature in the mouth was 97.~F.
The average normal temperature in the nose is 33C. (91.4F.).
The higher temperatures are in the range of inflamed nasal mucous membranes, a vital condition of inflammation.
Claims (3)
1. A nasal splint for helping the human nose maintain its mucous membranes in good condition, said splint compris-ing a U-shaped wire spring for straddling the nose and having two nubs, each of ellipsoidal-like shape, each leg of the U-shaped spring being embedded in and along a different one of the nubs, but holding the same only by friction, thereby each nub being capable of rotational movement relative the longitudinal axis of the leg and also capable of sliding movement along the longitudinal axis of the leg whereby the two nubs are adjustable with regard to each leg of the U-shaped spring to permit the nubs to be adjusted to human noses of different sizes.
2. Anew particular nasal splint for helping the human nose maintain its mucous membranes in good condition, said splint com-prising a U-shaped wire spring for straddling the nose and having two ellipsoidal-like nubs each of circular outline with two convex side faces, each leg of the U-shaped spring being embedded in a different one of the nubs and holding the same only by friction, thereby the nubs being capable of rotatable and slidable movement with respect to the longitudinal axis of the spring legs whereby the two nubs are adjustable to human noses of different sizes, and said spring of the splint being capable of pressing the nubs in on the sides of the nose in the area just above the alae to a degree sufficient to trap or minimize inhalation of airborne irritants entering the nose, but insufficient to block breathing and watery secretions therefrom.
3. A new particular nasal splint for helping the human nose maintain its mucous membranes in good condition, said splint com-prising a U-shaped wire spring for straddling the nose and having two ellipsoidal-like nubs each of circular outline with two convex side faces, each leg of the U-shaped spring being embedded in a different one of the nubs and holding the same only by friction, thereby the nubs being capable of rotatable and slidable movement with respect to the longitudinal axis of the spring legs whereby the two nubs are adjustable to human noses of different sizes, and said splint being capable of occluding the nasal cavities completely to prevent airborne irritants from entering the nose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000376781A CA1142828A (en) | 1981-05-04 | 1981-05-04 | Nasal protective method and device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000376781A CA1142828A (en) | 1981-05-04 | 1981-05-04 | Nasal protective method and device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1142828A true CA1142828A (en) | 1983-03-15 |
Family
ID=4119882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000376781A Expired CA1142828A (en) | 1981-05-04 | 1981-05-04 | Nasal protective method and device |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1142828A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111629690A (en) * | 2017-12-14 | 2020-09-04 | Wta-瓦塔纳比科技应用埃里利-艾普公司 | Automatic adjustment device for attachment to the nose of an animal |
-
1981
- 1981-05-04 CA CA000376781A patent/CA1142828A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111629690A (en) * | 2017-12-14 | 2020-09-04 | Wta-瓦塔纳比科技应用埃里利-艾普公司 | Automatic adjustment device for attachment to the nose of an animal |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210228414A1 (en) | Method for external ear canal pressure regulation to alleviate disorder symptoms | |
| US4573461A (en) | Nasal sealer and filter | |
| US20110307039A1 (en) | Device, method and system for treatment of sinusitis | |
| US4445508A (en) | Nasal protective method and device | |
| Fisher et al. | Direct and collateral effects of restraints and restraint fading | |
| US4033342A (en) | Nasal protective splint | |
| CN111068152A (en) | Dilator for aromatic substance | |
| Klaeger-Manzanell et al. | Two step recovery of vision in the amblyopic eye after visual loss and enucleation of the fixing eye. | |
| Nissani | Can taste aversion prevent bruxism? | |
| CA1142828A (en) | Nasal protective method and device | |
| GB2082922A (en) | Nasal protective device and method | |
| Neufeld et al. | Contingent application of a protective device to treat the severe self-biting behavior of a disturbed autistic child | |
| WO2019213037A1 (en) | Nasal mucosa heating and occlusion eyewear | |
| WO2018127878A2 (en) | Thermal massager mask for migraine relief | |
| CN106667762A (en) | Ear moxibustion instrument | |
| CA1113331A (en) | Nasal protective splint | |
| BR0311180A (en) | Methods for treating respiratory diseases and conditions using a selective inhibitor of inos | |
| Sataloff et al. | The environment in relation to otologic disease | |
| CN206026670U (en) | Ice platform magnetism fire appearance | |
| WO2018127889A2 (en) | Massager mask for migraine relief | |
| WO2018127875A2 (en) | Thermal mask with sound for migraine relief | |
| KR102121115B1 (en) | a pregnant woman's morning sickness Prevention System | |
| RU2181276C2 (en) | Method for treating the cases of neurosensory hypoacusis | |
| JPH0510815Y2 (en) | ||
| CN204521565U (en) | Prevent the moxibustion treatment head-shield of optic nerve systematic complication |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |